Amyris (AMRSQ) Stock Price
Amyris Price
Over the last 17 years Amyris grew revenue by 31.7% annually, reaching 269.85 M USD. For Amyris, the net margin of -195.9% is up versus -350.8% a few years ago.
Amyris stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Amyris over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Amyris stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Amyris's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Amyris Price |
|---|
Amyris Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Amyris Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.00 | 43.00 | 34.00 | 67.00 | 127.00 | 63.00 | 152.00 | 173.00 | 341.00 | 269.00 | 487.00 | 530.00 | 697.00 | 651.00 | 799.00 | 975.00 |
| -43.84 | 4.88 | -20.93 | 97.06 | 89.55 | -50.39 | 141.27 | 13.82 | 97.11 | -21.11 | 81.04 | 8.83 | 31.51 | -6.60 | 22.73 | 22.03 |
| 4.88 | 23.26 | -8.82 | 14.93 | 51.18 | 41.27 | 50.00 | 49.13 | 54.55 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| 2.00 | 10.00 | -3.00 | 10.00 | 65.00 | 26.00 | 76.00 | 85.00 | 186.00 | 11.00 | 19.91 | 21.67 | 28.50 | 26.62 | 32.67 | 39.87 |
| -110.00 | -95.00 | -108.00 | -88.00 | -55.00 | -131.00 | -121.00 | -123.00 | -177.00 | -592.00 | -309.00 | -250.00 | -116.00 | -196.00 | -68.00 | – |
| -268.29 | -220.93 | -317.65 | -131.34 | -43.31 | -207.94 | -79.61 | -71.10 | -51.91 | -220.07 | -63.45 | -47.17 | -16.64 | -30.11 | -8.51 | – |
| -235.00 | 2.00 | -218.00 | -97.00 | -201.00 | -223.00 | -242.00 | -331.00 | -270.00 | -528.00 | – | – | -102.00 | – | – | – |
| 14.63 | -100.85 | -11,000.00 | -55.50 | 107.22 | 10.95 | 8.52 | 36.78 | -18.43 | 95.56 | – | – | – | – | – | – |
| 5.00 | 5.20 | 8.50 | 15.90 | 32.30 | 60.40 | 364.75 | 364.75 | 364.75 | 364.75 | 364.75 | 364.75 | 364.75 | 364.75 | 364.75 | 364.75 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Amyris generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Amyris retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Amyris's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Amyris has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Amyris's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Amyris stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Amyris Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Amyris business model & stock analysis
Amyris SWOT Analysis
Strengths
Amyris Inc possesses several key strengths that contribute to its competitive advantage in the market:
- Advanced Bioengineering Technology: Amyris specializes in using its proprietary technology to engineer microbes and produce sustainable ingredients that have a wide range of applications.
- Diversified Product Portfolio: The company offers a diverse range of products, including specialty chemicals, flavors, fragrances, and cosmetic ingredients, catering to various industries and consumer needs.
- Strong Intellectual Property: Amyris has a robust portfolio of patents and intellectual property rights, providing a significant barrier to entry for competitors and ensuring the exclusivity of its innovative products.
- Strategic Partnerships: The company has established partnerships with global industry leaders, enabling access to distribution channels, resources, and expertise for scaling its operations.
Weaknesses
Despite its strengths, Amyris Inc also faces certain weaknesses that hinder its growth potential:
- High Research and Development Costs: The company invests a significant portion of its revenue into research and development activities, which may strain its financial resources in the short term.
- Dependence on Strategic Partnerships: While beneficial, Amyris relies heavily on strategic partnerships for manufacturing, marketing, and distribution support, exposing it to potential risks associated with those partnerships.
- Regulatory Compliance: As a provider of sustainable and biologically engineered products, Amyris must adhere to stringent regulatory requirements, which may cause delays and additional costs.
Opportunities
Amyris Inc can leverage the following opportunities to drive its growth and market position:
- Increasing Demand for Sustainable Products: Growing consumer awareness and demand for environmentally friendly and sustainable alternatives present a significant opportunity for Amyris to expand its customer base.
- Expansion into New Markets: The company can explore untapped markets and industries, such as pharmaceuticals, nutraceuticals, and agriculture, by utilizing its bioengineering capabilities and diverse product portfolio.
- Growing Clean Beauty Trend: The rising popularity of clean and natural beauty products provides an avenue for Amyris to capitalize on its cosmetic ingredient offerings and cater to the evolving preferences of consumers.
Threats
Despite the opportunities, Amyris Inc must also be aware of potential threats that could impact its business:
- Intense Competition: The bioengineering industry is becoming increasingly competitive, with numerous players vying for market share, which could lead to price pressures and potential loss of customers.
- Technological Advancements: Rapid advancements in bioengineering technology may lead to new competitors emerging with superior products or production methods, potentially disrupting Amyris' market position.
- Economic Factors: Fluctuations in the global economy, currency exchange rates, and commodity prices can have an adverse impact on Amyris' financial performance and profitability.
Amyris Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Amyris historical P/E ratio, EBIT multiple, and P/S ratio
Amyris annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Amyris shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Amyris stock splits
Amyris Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 5/7/2024 | -0.15USD | - | 93.68 MUSD | - | 2024 Q1 |
| 3/13/2024 | -0.29USD | - | 90.02 MUSD | - | 2023 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Amyris stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Amyris shareholder structure
| % | Name |
|---|---|
27.20335% | |
1.03907% | |
0.07881% | |
0.01754% | |
0.00443% | |
0.00343% |
Amyris Executives and Management Board
15 members · avg. age 61 · 33 % women
Mr. Han Kieftenbeld (58)
Interim Chief Executive Officer, Chief Financial Officer, Chief Administrative Officer
1.08 M USD
Management
Ms. Elizabeth Dreyer (60)
Chief Accounting Officer, Corporate Controller
Ms. Doris Choi (44)
General Counsel, Secretary
Mr. Philip Gund
Chief Restructuring Officer
Board of Directors
Ms. Ana Dutra (58)
Independent Director
Mr. John Doerr (71)
Independent Director
Mr. Steven Mills (67)
Independent Director · since 2012
Mr. James Mccann (72)
Independent Director
Dr. Frank Kung (74)
Independent Director
Mr. Ryan Panchadsaram (38)
Independent Director
Frequently asked questions about Amyris
Amyris Inc is a leading biotechnology company focused on sustainable ingredients for various industries. Their business model revolves around the production and commercialization of high-performance sustainable products. With a strong emphasis on innovation, Amyris utilizes its proprietary synthetic biology platform to engineer microbes and produce sustainable alternatives to petroleum-derived chemicals. These include renewable ingredients for cosmetics, fragrances, flavors, and nutraceuticals, as well as renewable feedstocks for the production of renewable diesel and jet fuels. By enabling the transition to a more sustainable economy, Amyris Inc aims to deliver environmental benefits while providing quality products to its customers.
Amyris Inc is primarily active in the renewable chemicals and sustainable fuels industries.
The main competitors of Amyris Inc in the market are Evolva Holding SA, Synthetic Genomics Inc, and Intrexon Corporation.
Amyris Inc. is a leading biotechnology company known for its sustainable solutions in the fields of health and wellness, clean beauty, and renewable chemicals. Founded in 2003, Amyris has a rich history marked by its commitment to advancements in synthetic biology. The company's groundbreaking research has enabled the production of a wide range of innovative products, including sustainable ingredients, fragrances, and high-performance materials. Amyris has collaborated with numerous partners and has expanded its global presence, ensuring the adoption of its renewable solutions worldwide. With a strong focus on environmental and societal well-being, Amyris Inc. continues to revolutionize industries through sustainable, nature-inspired innovations.
Amyris Inc has achieved several significant milestones in its trajectory. Notably, the company successfully developed and commercialized its proprietary yeast strain technology, enabling the production of high-value molecules more sustainably. Amyris Inc also established strategic partnerships with various global leaders, expanding its product portfolio and market reach. Additionally, the company made remarkable progress in the renewable energy sector, delivering renewable diesel and jet fuel solutions. Amyris Inc's commitment to sustainability and innovation has garnered accolades, including recognition as a Fast Company Most Innovative Company and a World Economic Forum Technology Pioneer. The company's continuous growth and advancements solidify its position as an industry leader in sustainable solutions.
Amyris Inc is primarily present in countries and regions across the globe, including the United States, Brazil, Europe, and Asia.
Amyris Inc represents a set of core values and corporate philosophy that drive its business operations. The company is committed to delivering sustainable solutions through its advanced biotechnology platform. Amyris focuses on providing renewable products across various industries, including clean beauty, flavors, fragrances, and sweeteners. With an emphasis on innovation, Amyris strives to create high-performance products, enhancing the quality of life while minimizing the environmental impact. The company's dedication to scientific excellence, integrity, and social responsibility enables Amyris to fulfill its mission of positively transforming the world. Amyris Inc consistently pursues its goal of sustainable development and improving global resource efficiency through innovative biotechnology solutions.
8 analysts currently rate the Amyris stock: 0 recommend buying, 3 holding and 5 selling.
Converted at the current exchange rate, the Amyris share trades at 0.00 EUR (0.00 USD).
The Amyris share (AMRSQ) is listed on 5 stock exchanges, including: NASDAQ (AMRS), Frankfurt (3A01.F), München (3A01.MU), Düsseldorf (3A01.DU), SIX (Zürich) (3A01.SW).
Amyris Inc. is an American biotechnology company based in Emeryville, California. Founded in 2003, the company specializes in the development and production of molecules that can serve as the basis for a variety of products, particularly in the cosmetics, skincare, body and hair care, perfume, and fragrance industries. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the construction and optimization of microorganisms capable of producing specific molecules, such as essential oils, fats and waxes, sugars, flavors, and other compounds, from sustainable raw materials. The company's focus is on producing molecules from renewable resources such as sugarcane, corn, cellulose, and other bio-based materials. The molecules produced by Amyris are used either directly as end products or as ingredients in other products. Amyris has several divisions, including "Ingredients," "Cosmetics & Personal Care," "Fragrances & Flavors," and "Sweeteners & Nutraceuticals." In the "Ingredients" division, the company produces a variety of molecules that can be used as starting materials for the production of cosmetics and personal care products, cleaning agents, lubricants, and other products. Examples of products include squalene, hyaluronic acid, vitamin E, ferulic acid, caprylic/capric triglycerides, and others. In the "Cosmetics & Personal Care" division, Amyris also offers its own skincare, body, and hair care products based on sustainable, organic ingredients. These include nourishing facial oils, moisturizers, cleansers, shampoos, conditioners, and others. In the "Fragrances & Flavors" division, Amyris produces essential oils, flavors, and fragrances that are used in a variety of applications, including perfumes, room fragrances, scented candles, and aromatherapy products. Key products include lavender oil, cinnamon bark oil, lemon oil, vanillin, and others. Finally, Amyris also offers products in the "Sweeteners & Nutraceuticals" category, including plant-based sweeteners such as rebaudioside A and others, as well as dietary supplements based on omega-3 fatty acids, vitamin D3, and other ingredients. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the development and production of molecules that can be used as raw materials for a variety of products. By using sustainable raw materials and producing molecules in an environmentally friendly way, the company has established itself as a pioneer in sustainable chemistry. With a wide range of products and a strong presence in global markets, Amyris Inc. is well positioned to continue growing in the coming years and promote awareness of sustainable innovations in the chemical industry.
The revenue cannot currently be calculated for Amyris.
The profit cannot currently be calculated for Amyris.
The P/E ratio cannot be calculated for Amyris at the moment.
The P/S cannot be calculated for Amyris currently.
The Eulerpool Quality Score for Amyris is 4/10.
The ISIN of Amyris is US03236M2008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Amyris is A2DS41. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Amyris is AMRSQ. The ticker symbol is used to trade Amyris shares on the stock exchange.
Amyris paid dividends every year for the past 0 years.
Amyris is assigned to the 'Commodities' sector.
The dividends of Amyris are distributed in USD.
Amyris stock
Amyris Peer Group
Amyris Ticker
Amyris FIGI
All fundamentals and in-depth analysis of Amyris
Our stock analysis for Amyris stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amyris. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.